Skip to main content
Caplight Logo









Clinical Microbiomics

Clinical Microbiomics

Private
CopenhagenHealthcare & Life Scienceshttps://clinical-microbiomics.com/

Last Round

Early Funding

Oct 11, 2022

Total Funding Raised

$9.7M

Company Overview

Clinical Microbiomics is a biotechnology company that provides multi-omics research services, including microbiome and metabolome analysis, for pharmaceutical, academic, and consumer health sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

microbiome researchcontract research organizationCROmulti-omicsshotgun metagenomicsmetabolomicsbioinformaticsclinical trial supportmetatranscriptomicsGxP compliancemicrobiome analysisdrug discoveryprecision medicinebiotech servicesgut health researchmicrobiome sequencing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Clinical Microbiomics Comparables

Compare Clinical Microbiomics with similar companies based on industry and business-model similarity.

Clinical Microbiomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SeqBiome Ltd
86%
BaseClear B.V.
80%
OraSure Technologies Inc
78%

Clinical Microbiomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 11, 2022

Clinical Microbiomics Investors

Notable investors and investment history

Clinical Microbiomics investors
InvestorRounds
Seventure PartnersEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 11, 2022

    $9.7M round led by Seventure Partners

Clinical Microbiomics Filings

Explore SEC and related filing metadata, where available.

Clinical Microbiomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Clinical Microbiomics's valuation, stock price, and market status.

Is Clinical Microbiomics a public or private company?

Clinical Microbiomics is a private company.

What is the current stock price of Clinical Microbiomics?

Clinical Microbiomics is a private company with no public stock price. Caplight tracks Clinical Microbiomics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Clinical Microbiomics worth (valuation)?

Valuation information for Clinical Microbiomics is not publicly available.

Can I buy Clinical Microbiomics stock?

Clinical Microbiomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Clinical Microbiomics's last funding round?

Clinical Microbiomics's most recent funding round was Early Funding on October 11, 2022.

Who are the main investors in Clinical Microbiomics?

Key investors in Clinical Microbiomics include Seventure Partners.

Will Clinical Microbiomics IPO soon?

No public IPO plans have been announced for Clinical Microbiomics.

How can I track Clinical Microbiomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Clinical Microbiomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Year Founded2015
Last FundingOct 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?